Search research articles
Contact Us
Filters
Showing results (161-170 of 293) with videos related to
Page
of 30
Sort By:
Clinical Breast Cancer
|
January 5, 2016
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors
Komal Jhaveri, Sarat Chandarlapaty, Neil Iyengar, et al.
Histopathology
|
February 12, 2020
Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation
Francisco Beca, Ana P M Sebastiao, Fresia Pareja, et al.
Clinical Breast Cancer
|
May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
Shanu Modi, Violante E Currie, Andrew D Seidman, et al.
British Journal of Cancer
|
September 2, 2025
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation
Huizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 3, 2020
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
Raza Syed Hoda, Edi Brogi, Carlos Henrique Dos Anjos, et al.
British Journal of Cancer
|
August 5, 2025
Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation
Huizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
NPJ Breast Cancer
|
October 2, 2025
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer
Nour Abuhadra, Fresia Pareja, Charlie White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
Blase N Polite, Constance Cirrincione, Gini F Fleming, et al.
Cancer
|
August 12, 2003
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy
Alice B Kornblith, James E Herndon, Raymond B Weiss, et al.
ACS Infectious Diseases
|
November 3, 2024
Global Health Priority Box─Proactive Pandemic Preparedness
Anna Adam, Dominique Besson, Rob Bryant, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 293) with videos related to
Sort By:
Page
of 30
Clinical Breast Cancer
|
January 5, 2016
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors
Komal Jhaveri, Sarat Chandarlapaty, Neil Iyengar, et al.
Histopathology
|
February 12, 2020
Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation
Francisco Beca, Ana P M Sebastiao, Fresia Pareja, et al.
Clinical Breast Cancer
|
May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
Shanu Modi, Violante E Currie, Andrew D Seidman, et al.
British Journal of Cancer
|
September 2, 2025
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation
Huizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 3, 2020
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
Raza Syed Hoda, Edi Brogi, Carlos Henrique Dos Anjos, et al.
British Journal of Cancer
|
August 5, 2025
Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation
Huizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
NPJ Breast Cancer
|
October 2, 2025
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer
Nour Abuhadra, Fresia Pareja, Charlie White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
Blase N Polite, Constance Cirrincione, Gini F Fleming, et al.
Cancer
|
August 12, 2003
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy
Alice B Kornblith, James E Herndon, Raymond B Weiss, et al.
ACS Infectious Diseases
|
November 3, 2024
Global Health Priority Box─Proactive Pandemic Preparedness
Anna Adam, Dominique Besson, Rob Bryant, et al.
Page
of 30